Laporan Laba Rugi (TTM)
Laporan Laba Rugi Diamyd Medical AB (publ) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 11-30 |
2021 02-28 |
2021 05-31 |
2021 08-31 |
2021 11-30 |
2022 02-28 |
2022 05-31 |
2022 08-31 |
2022 11-30 |
2023 02-28 |
2023 08-31 |
2023 11-30 |
2024 02-29 |
2024 05-31 |
2024 08-31 |
2024 11-30 |
2025 02-28 |
2025 05-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -20.72 | 16.18 | -9.64 | -19.76 | 168.47 | -28.62 | 16.71 | 39.65 | -33.75 | 30.00 | -32.42 | -23.58 | -34.04 | -30.11 | -6.92 | 50.41 | -29.12 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Change (%) | 8.44 | -16.03 | -39.81 | 8.20 | 22.69 | 23.01 | 7.81 | -0.89 | -9.83 | -7.65 | 12.60 | -8.02 | 3.67 | -4.92 | -1.56 | 7.83 | 0.20 | |
| % of Revenue | 1,500.99 | 2,053.11 | 1,483.93 | 988.54 | 1,333.00 | 609.17 | 1,049.87 | 969.82 | 688.33 | 936.90 | 665.57 | 1,108.94 | 1,334.75 | 2,097.85 | 2,853.85 | 3,018.18 | 2,163.74 | 3,058.91 |
| Gross Operating Profit | -4 | -5 | -4 | -2 | -3 | -3 | -4 | -4 | -4 | -4 | -3 | -4 | -3 | -4 | -4 | -4 | -4 | -4 |
| Change (%) | 10.52 | -17.68 | -41.99 | 11.34 | 10.87 | 33.15 | 6.87 | -5.55 | -5.76 | -12.15 | 20.56 | -6.47 | 6.72 | -3.66 | -1.37 | 6.37 | 1.62 | |
| % of Revenue | -1,400.99 | -1,953.11 | -1,383.93 | -888.54 | -1,233.00 | -509.17 | -949.87 | -869.82 | -588.33 | -836.90 | -565.57 | -1,008.94 | -1,234.75 | -1,997.85 | -2,753.85 | -2,918.18 | -2,063.74 | -2,958.91 |
| SG&A | 18 | 20 | 23 | 26 | 27 | 29 | 29 | 32 | 34 | 36 | 40 | 42 | 43 | 44 | 45 | 48 | 50 | 53 |
| Change (%) | 10.92 | 18.87 | 9.36 | 5.31 | 6.07 | 0.41 | 11.05 | 8.03 | 5.62 | 8.97 | 5.70 | 3.51 | 1.49 | 1.61 | 6.88 | 4.53 | 6.46 | |
| % of Revenue | 5,847.70 | 8,181.74 | 8,370.71 | 10,130.83 | 13,297.04 | 5,253.58 | 7,390.75 | 7,032.60 | 5,440.38 | 8,673.57 | 7,270.15 | 11,370.73 | 15,400.71 | 23,697.85 | 34,451.54 | 39,559.50 | 27,492.86 | 41,293.80 |
| R&D | 18 | 20 | 42 | 57 | 81 | 85 | 68 | 76 | 66 | 71 | 70 | 66 | 69 | 82 | 96 | 105 | 119 | 124 |
| Change (%) | 11.93 | 111.24 | 33.80 | 42.86 | 4.54 | -19.66 | 10.77 | -12.65 | 7.22 | -1.22 | -5.75 | 5.15 | 18.07 | 17.95 | 8.71 | 13.62 | 3.67 | |
| % of Revenue | 5,912.17 | 8,347.72 | 15,177.50 | 22,474.31 | 40,013.79 | 15,580.37 | 17,537.02 | 16,644.71 | 10,411.04 | 16,850.24 | 12,803.85 | 17,856.37 | 24,568.09 | 43,979.57 | 74,218.46 | 86,680.99 | 65,478.02 | 95,773.64 |
| OpEx | 40 | 45 | 71 | 86 | 113 | 119 | 104 | 115 | 109 | 114 | 116 | 115 | 120 | 138 | 153 | 165 | 182 | 189 |
| Change (%) | 13.48 | 56.69 | 21.71 | 30.43 | 5.96 | -13.10 | 11.31 | -5.74 | 4.86 | 2.05 | -1.41 | 4.18 | 15.67 | 10.51 | 7.83 | 10.33 | 3.86 | |
| % of Revenue | 13,121.05 | 18,782.57 | 25,331.79 | 34,120.55 | 55,464.04 | 21,889.91 | 26,649.36 | 25,416.30 | 17,155.99 | 27,156.67 | 21,317.22 | 31,098.92 | 42,394.68 | 74,347.85 | 117,550.00 | 136,176.86 | 99,887.91 | 146,363.57 |
| Operating Income | -40 | -45 | -71 | -86 | -112 | -119 | -103 | -115 | -108 | -114 | -116 | -114 | -119 | -138 | -153 | -165 | -182 | -189 |
| Change (%) | 13.75 | 56.91 | 21.83 | 30.58 | 5.66 | -13.03 | 11.29 | -5.92 | 5.09 | 1.94 | -1.26 | 4.27 | 15.79 | 10.56 | 7.84 | 10.30 | 3.89 | |
| % of Revenue | -13,021.05 | -18,682.57 | -25,231.79 | -34,020.55 | -55,364.04 | -21,789.91 | -26,549.36 | -25,316.30 | -17,055.99 | -27,056.67 | -21,217.22 | -30,998.92 | -42,294.68 | -74,247.85 | -117,450.00 | -136,076.86 | -99,787.91 | -146,263.57 |
| Interest Expense | -27 | -1 | -1 | -0 | -1 | -1 | -0 | -1 | -4 | -0 | -2 | -2 | -2 | -0 | -1 | -1 | -2 | |
| Change (%) | -98.04 | -0.00 | -14.53 | 9.34 | -63.39 | 338.34 | 269.43 | -99.93 | 53,000.00 | 30.76 | -0.00 | -99.62 | 12,987.50 | -23.69 | 103.63 | |||
| % of Revenue | -8,916.12 | -219.92 | -189.29 | -179.05 | -115.96 | -177.63 | -55.73 | -174.92 | -975.48 | -0.55 | -431.71 | -738.65 | -1,119.89 | -6.15 | -865.29 | -439.01 | -1,261.24 | |
| Net Income | 121 | 99 | 74 | 60 | -83 | -106 | -91 | -104 | -99 | -115 | -116 | -116 | -120 | -140 | -152 | -155 | -171 | -175 |
| Change (%) | -18.18 | -25.70 | -18.65 | -237.62 | 28.77 | -14.81 | 14.18 | -4.65 | 16.47 | 0.97 | -0.15 | 3.69 | 16.18 | 8.76 | 2.23 | 10.06 | 2.23 | |
| % of Revenue | 39,936.84 | 41,220.75 | 26,360.71 | 23,733.60 | -40,708.37 | -19,525.32 | -23,305.40 | -22,801.10 | -15,568.61 | -27,371.90 | -21,258.79 | -31,409.21 | -42,617.73 | -75,065.59 | -116,807.69 | -128,289.26 | -93,871.98 | -135,390.70 |
Source: Capital IQ
